| Susan Muller, MD | |
|
119 Lawrence St, Saratoga Springs, NY 12866-1346 | |
| (518) 584-7361 | |
| (518) 584-7930 |
| Full Name | Susan Muller |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 33 Years |
| Location | 119 Lawrence St, Saratoga Springs, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093701617 | NPI | - | NPPES |
| 00697301 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 190725 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kindred At Home (ballston Lake) | Ballston lake, NY | Home health agency |
| Community Hospice, Inc, The | Rensselaer, NY | Hospice |
| Saratoga Hospital | Saratoga springs, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saratoga Hospital | 6406740273 | 314 |
News Archive
Use of intra-arterial therapy in octogenarian patients with stroke does not appear to increase their risk for dying in hospital above that seen with use of intravenous recombinant tissue plasminogen activator, a large study suggests.
A factor that helps optimize brain formation and function may also provide clues about whether patients suffering with schizophrenia are headed toward relapse, researchers say.
A study by researchers at Mayo Clinic's campus in Florida and Washington University School of Medicine adds a new twist to the body of evidence suggesting human obesity is due in part to genetic factors. While studying hormone receptors in laboratory mice, neuroscientists identified a new molecular player responsible for the regulation of appetite and metabolism.
President Joe Biden's "Build Back Better" social spending bill passed the House last week, but the legislation faces a new and different set of hurdles in the Senate, where it will need the support of every single Democrat, plus approval by the Senate parliamentarian.
The U.S FDA have pushed back the deadline for deciding whether to approve an experimental anticlotting drug developed jointly by Pfizer Inc. and Bristol-Myers Squibb Co. The companies said late Wednesday that the Food and Drug Administration has set a new target date of June 28 for deciding whether to approve Eliquis. That's three months later than originally scheduled.
› Verified 8 days ago
| Entity Name | Saratoga Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033371166 PECOS PAC ID: 6406740273 Enrollment ID: O20040402000837 |
News Archive
Use of intra-arterial therapy in octogenarian patients with stroke does not appear to increase their risk for dying in hospital above that seen with use of intravenous recombinant tissue plasminogen activator, a large study suggests.
A factor that helps optimize brain formation and function may also provide clues about whether patients suffering with schizophrenia are headed toward relapse, researchers say.
A study by researchers at Mayo Clinic's campus in Florida and Washington University School of Medicine adds a new twist to the body of evidence suggesting human obesity is due in part to genetic factors. While studying hormone receptors in laboratory mice, neuroscientists identified a new molecular player responsible for the regulation of appetite and metabolism.
President Joe Biden's "Build Back Better" social spending bill passed the House last week, but the legislation faces a new and different set of hurdles in the Senate, where it will need the support of every single Democrat, plus approval by the Senate parliamentarian.
The U.S FDA have pushed back the deadline for deciding whether to approve an experimental anticlotting drug developed jointly by Pfizer Inc. and Bristol-Myers Squibb Co. The companies said late Wednesday that the Food and Drug Administration has set a new target date of June 28 for deciding whether to approve Eliquis. That's three months later than originally scheduled.
› Verified 8 days ago
| Entity Name | Saratoga Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629415740 PECOS PAC ID: 6406740273 Enrollment ID: O20130815000467 |
News Archive
Use of intra-arterial therapy in octogenarian patients with stroke does not appear to increase their risk for dying in hospital above that seen with use of intravenous recombinant tissue plasminogen activator, a large study suggests.
A factor that helps optimize brain formation and function may also provide clues about whether patients suffering with schizophrenia are headed toward relapse, researchers say.
A study by researchers at Mayo Clinic's campus in Florida and Washington University School of Medicine adds a new twist to the body of evidence suggesting human obesity is due in part to genetic factors. While studying hormone receptors in laboratory mice, neuroscientists identified a new molecular player responsible for the regulation of appetite and metabolism.
President Joe Biden's "Build Back Better" social spending bill passed the House last week, but the legislation faces a new and different set of hurdles in the Senate, where it will need the support of every single Democrat, plus approval by the Senate parliamentarian.
The U.S FDA have pushed back the deadline for deciding whether to approve an experimental anticlotting drug developed jointly by Pfizer Inc. and Bristol-Myers Squibb Co. The companies said late Wednesday that the Food and Drug Administration has set a new target date of June 28 for deciding whether to approve Eliquis. That's three months later than originally scheduled.
› Verified 8 days ago
| Entity Name | Saratoga Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073569331 PECOS PAC ID: 6406740273 Enrollment ID: O20140724001117 |
News Archive
Use of intra-arterial therapy in octogenarian patients with stroke does not appear to increase their risk for dying in hospital above that seen with use of intravenous recombinant tissue plasminogen activator, a large study suggests.
A factor that helps optimize brain formation and function may also provide clues about whether patients suffering with schizophrenia are headed toward relapse, researchers say.
A study by researchers at Mayo Clinic's campus in Florida and Washington University School of Medicine adds a new twist to the body of evidence suggesting human obesity is due in part to genetic factors. While studying hormone receptors in laboratory mice, neuroscientists identified a new molecular player responsible for the regulation of appetite and metabolism.
President Joe Biden's "Build Back Better" social spending bill passed the House last week, but the legislation faces a new and different set of hurdles in the Senate, where it will need the support of every single Democrat, plus approval by the Senate parliamentarian.
The U.S FDA have pushed back the deadline for deciding whether to approve an experimental anticlotting drug developed jointly by Pfizer Inc. and Bristol-Myers Squibb Co. The companies said late Wednesday that the Food and Drug Administration has set a new target date of June 28 for deciding whether to approve Eliquis. That's three months later than originally scheduled.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Susan Muller, MD 119 Lawrence St, Saratoga Springs, NY 12866-1346 Ph: (518) 584-7361 | Susan Muller, MD 119 Lawrence St, Saratoga Springs, NY 12866-1346 Ph: (518) 584-7361 |
News Archive
Use of intra-arterial therapy in octogenarian patients with stroke does not appear to increase their risk for dying in hospital above that seen with use of intravenous recombinant tissue plasminogen activator, a large study suggests.
A factor that helps optimize brain formation and function may also provide clues about whether patients suffering with schizophrenia are headed toward relapse, researchers say.
A study by researchers at Mayo Clinic's campus in Florida and Washington University School of Medicine adds a new twist to the body of evidence suggesting human obesity is due in part to genetic factors. While studying hormone receptors in laboratory mice, neuroscientists identified a new molecular player responsible for the regulation of appetite and metabolism.
President Joe Biden's "Build Back Better" social spending bill passed the House last week, but the legislation faces a new and different set of hurdles in the Senate, where it will need the support of every single Democrat, plus approval by the Senate parliamentarian.
The U.S FDA have pushed back the deadline for deciding whether to approve an experimental anticlotting drug developed jointly by Pfizer Inc. and Bristol-Myers Squibb Co. The companies said late Wednesday that the Food and Drug Administration has set a new target date of June 28 for deciding whether to approve Eliquis. That's three months later than originally scheduled.
› Verified 8 days ago
Dr. Jama Lorynn Peacock Birsett, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 68 West Ave Ste 3, Saratoga Springs, NY 12866 Phone: 518-450-9180 Fax: 518-886-1690 | |
Dr. Bert W Pyle Iii, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 Church St, Saratoga Springs, NY 12866 Phone: 518-587-1141 | |
Eric C. Borden, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3044 Route 50, Saratoga Springs, NY 12866 Phone: 518-886-5800 Fax: 518-886-5805 | |
Robert Nielson, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 3044 Route 50, Saratoga Springs, NY 12866 Phone: 518-886-5800 | |
Paul Joseph Okosky, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3044 Route 50, Saratoga Springs, NY 12866 Phone: 518-886-5800 Fax: 518-886-5805 | |
Dr. Stephen Offord, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 Church St, Saratoga Springs, NY 12866 Phone: 518-587-1141 |